Related Experiment Video
Updated: Jul 19, 2025

09:58
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
13.8K
Splicing defects in rare diseases: transcriptomics and machine learning strategies towards genetic diagnosis
Robert Wang1,2, Ingo Helbig3,4,5,6, Andrew C Edmondson1,7
1Center for Computational and Genomic Medicine, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Briefings in Bioinformatics
|August 14, 2023
Summary
Investigating genetic diseases requires better detection of splicing variants. RNA sequencing and computational tools improve the identification of these disease-causing variants, aiding rare disease diagnosis.
Area of Science:
- Genetics
- Molecular Biology
- Bioinformatics
Background:
- Genomic variants impacting pre-messenger RNA splicing are implicated in numerous rare genetic disorders.
- Current genetic diagnostic and variant interpretation methods often fail to identify splice-altering variants, contributing to a diagnostic gap.
- There is a growing need for advanced methods to detect and interpret pathogenic splicing variants for improved patient care and research.
Approach:
- This review summarizes recent advancements and challenges in utilizing RNA sequencing (RNA-Seq) technologies for investigating rare genetic diseases.
- It discusses the role of computational splicing prediction tools as complementary methods to identify disease-causing variants associated with splicing defects.
- The review highlights the synergy between experimental and computational approaches in understanding splicing in rare diseases.
Key Points:
- RNA sequencing offers powerful insights into gene expression and splicing patterns relevant to rare diseases.
- Computational tools are increasingly vital for predicting the functional impact of splicing variants, especially those missed by traditional analyses.
- Integrating RNA-Seq data with predictive modeling enhances the detection of pathogenic splicing variants.
Conclusions:
- Continued progress in sequencing technologies and predictive modeling will deepen our understanding of splicing regulation.
- These advancements are crucial for bridging the diagnostic gap and improving outcomes for patients with rare genetic diseases.
- A comprehensive approach combining RNA sequencing and computational analysis is essential for accurate diagnosis and research in rare genetic disorders.
Related Concept Videos
Alternative RNA Splicing
21.3K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.3K
RNA Splicing
56.5K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.5K
Pre-mRNA Processing: RNA Splicing
5.3K
5.3K
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K

